Monica Cresci
National Research Council
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Monica Cresci.
American Journal of Cardiology | 2011
Monica Cresci; Ilenia Foffa; Lamia Ait-Ali; Silvia Pulignani; Emilio Antonio Luca Gianicolo; Nicoletta Botto; Eugenio Picano; Maria Grazia Andreassi
Congenital heart defects (CHDs) are the most prevalent of all birth malformations arising from the complex interplay of environmental exposures and genes. Modifiable environmental risk factors are still largely unknown, especially for paternal exposure. The aim of the present study was to examine the association between the environmental exposures of both parents and CHD risk and to explore the modification effect of metabolizing gene polymorphisms in children who lack the genetic capacity to produce the glutathione S-transferase (GST) GSTM1 and GSTT1 enzymes. A total of 330 parents of a child with CHD and 330 parents of a child without any congenital malformations were compared in terms of lifestyle habits and toxicant exposure. GST gene polymorphisms were investigated in 180 patients with CHD (104 males, age 4.9 ± 5.8 years). Paternal smoking (≥15 cigarettes/day) was significantly associated with CHD risk (odds ratio [OR] 2.1, 95% confidence interval [CI] 1.3 to 3.5, p = 0.002). Both maternal (OR 2.6, 95% CI 1.6 to 4.2, p <0.0001) and paternal (OR 2.5, 95% CI 1.6 to 3.8, p <0.0001) occupational/environmental exposures increased the risk of CHD. Also, a significant additive risk (OR 4.5, 95% CI 2.5 to 8.3, p <0.0001) was found when both parents were exposed to toxicants. Both maternal (OR 3.6, 95% CI 1.1 to 11.2, p = 0.03) and paternal (OR 3.3, 95% CI 1.0 to 10.8, p = 0.03) exposure to toxicants increased the CHD risk in children who carried the combined null GST genotypes. The effect for the combined null GST genotypes was also stronger (OR 6.5, 95% CI 1.5 to 28.0) when both parents were exposed. In conclusion, paternal smoking and exposure to toxicants for both parents affect the risk of children with CHD. Polymorphisms in GST genes can modify a persons risk of toxicant exposure-induced disease.
Current Pharmaceutical Design | 2010
Emilio Antonio Luca Gianicolo; Monica Cresci; Lamia Ait-Ali; Ilenia Foffa; Maria Grazia Andreassi
Cigarette smoking is a powerful human germ cell mutagen and teratogen. Congenital heart defects (CHD) is the most prevalent of all birth defects and leading cause of death in the first year of life. The purpose of this article is to review the epidemiology of the impact of cigarette smoking on CHD risk as well as to discuss the potential biological mechanisms of smoking-mediated abnormal cardiac development. Although epidemiological studies of association between parental smoking and CHD are limited, biological evidence support the concept that cigarette smoking may substantially contribute to the aetiology of CHD through induction of either male and female germ-cell mutation or interference with epigenetic pathways. Further research is needed to better define the relationship between parental smoking and the risk of heart defects as well as to assess parental-fetal gene-smoking interactions.
American Journal of Medical Genetics Part A | 2014
Anwar Baban; Letizia Pitto; Silvia Pulignani; Monica Cresci; Laura Mariani; Carolina Gambacciani; Maria Cristina Digilio; Giacomo Pongiglione; Sonia B. Albanese
Holt–Oram syndrome (HOS) is a rare autosomal dominant disorder characterized by upper limb defects and congenital heart defects (CHD), which are often simple septal and conduction defects, less frequently complex CHDs. We report on a 9 year‐old boy with clinical and radiologic features of HOS consisting of bilateral asymmetric hypoplastic thumbs, generalized brachydactyly, limited supination due to radioulnar synostosis, and sloping shoulders, and intermediate atrioventricular canal defect (AVCD) with aortic coarctation. A de novo, previously described mutation, (Arg279ter) was identified in the TBX5 gene. Molecular characterization of this mutation was carried out due to the atypical CHD. In order to investigate whether the mutated transcript of TBX5 was able to escape the post‐transcriptional surveillance mechanism and to produce a truncated TBX5 protein, we analyzed the TBX5 transcript, and protein pattern in HOS, and WT cardiac tissues. Our results demonstrate that the mutant TBX5 transcript is cleared by the cellular mechanism of surveillance. This data provides some support for the hypothesis that a dominant negative mutation, which strongly impairs the WT allele, might be too hazardous to be maintained. The literature suggests that HOS is relatively common among syndromes associated with AVCD.
Proceedings of SPIE | 2013
L. Labate; Maria Grazia Andreassi; Federica Baffigi; Giuseppina Basta; Ranieri Bizzarri; Andrea Borghini; Giuliana Candiano; Carlo Casarino; Monica Cresci; Fabio Di Martino; Lorenzo Fulgentini; Francesco Ghetti; Maria Carla Gilardi; A. Giulietti; P Koster; Francesco Lenci; T. Levato; Yuji Oishi; Giorgio Ivan Russo; Antonella Sgarbossa; C. Traino; L. A. Gizzi
Laser-driven electron accelerators based on the Laser Wakefield Acceleration process has entered a mature phase to be considered as alternative devices to conventional radiofrequency linear accelerators used in medical applications. Before entering the medical practice, however, deep studies of the radiobiological effects of such short bunches as the ones produced by laser-driven accelerators have to be performed. Here we report on the setup, characterization and first test of a small-scale laser accelerator for radiobiology experiments. A brief description of the experimental setup will be given at first, followed by an overview of the electron bunch characterization, in particular in terms of dose delivered to the samples. Finally, the first results from the irradiation of biological samples will be briefly discussed.
Translational Research | 2013
Silvia Pulignani; Monica Cresci; Maria Grazia Andreassi
Wereadwith great interest the paper byWu et al on the genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defect (VSD). The authors provide new important ideas about the potential role of genetic variants within regulatory region rather than the codifying sequences that may contribute to the etiology of VSD, the most common type of congenital heart defect (CHD). In this study, 5 heterozygous sequence variants were found within the promoter region of GATA4 gene in VSD patients but in none of the healthy controls. Although these variants do not interrupt the regulatory promoter regions, they seem to significantly alter the transcriptional activity of GATA4 gene promoter, which may contribute to the VSD. In another study published by the same authors, functional analysis showed that sequence variants within promoter regions significantly enhance the transcriptional activities of the NKX2-5 gene, which may lead to upregulated NKX2-5 gene expression, contributing to the VSD etiology. We believe that these observations underlie that the causative factors and the molecular mechanisms involved in the CHD etiology still remain largely elusive. In recent years, several lines of evidence have highlighted the importance of GATA4, in association with a variety of binding partners like NKX2-5, in a specific transcriptional complex that confer tissue-specific gene expression during cardiogenesis and that can be altered during the development of CHD. Indeed, mutations leading to gene haploinsufficiency in key cardiac transcription factors (TFs) are responsible for inherited and sporadic CHDs. Nevertheless, the study of genetic basis of CHDs is complicated by the fact that a given structural defect can be caused by more than one gene because TFs
International Journal of Environmental Research and Public Health | 2009
Ilenia Foffa; Monica Cresci; Maria Grazia Andreassi
Cardiac diagnostic or therapeutic testing is an essential tool for diagnosis and treatment of cardiovascular disease, but it also involves considerable exposure to ionizing radiation. Every exposure produces a corresponding increase in cancer risk, and risks are highest for radiation exposure during infancy and adolescence. Recent studies on chromosomal biomarkers corroborate the current radioprotection assumption showing that even modest radiation load due to cardiac catheter-based fluoroscopic procedures can damage the DNA of the cell. In this article, we review the biological and clinical risks of cardiac imaging employing ionizing radiation. We also discuss the perspectives offered by the use of molecular biomarkers in order to better assess the long-term development of health effects.
Recenti progressi in medicina | 2011
Silvia Pulignani; Ilenia Foffa; Monica Cresci; Simona Vittorini; Lamia Ait-Ali; Maria Grazia Andreassi
Single gene mutations in Gata4 and Nkx2.5 genes have been identified as a causative factor for various clinical forms of hereditary congenital heart diseases (CHDs), especially for cardiac septal defects. However, the role of Gata4 and Nkx2.5 mutations in familial CHD is not clear yet. We report 5 cases of familial CHD with a positive history of cardiac septal defects. Our data suggest that mutations of either the Gata4 or Nkx2.5 genes are very uncommonly found in familial cases of CHD, supporting the genetic heterogeneity of cardiac congenital defects and the limitation of genetic testing in clinical setting.
Radiation Research | 2016
Maria Grazia Andreassi; Andrea Borghini; Silvia Pulignani; Federica Baffigi; Lorenzo Fulgentini; P. Koester; Monica Cresci; Cecilia Vecoli; Debora Lamia; Giorgio Ivan Russo; Daniele Panetta; Maria Tripodi; L. A. Gizzi; L. Labate
Laser-driven electron accelerators are capable of producing high-energy electron bunches in shorter distances than conventional radiofrequency accelerators. To date, our knowledge of the radiobiological effects in cells exposed to electrons using a laser-plasma accelerator is still very limited. In this study, we compared the dose-response curves for micronucleus (MN) frequency and telomere length in peripheral blood lymphocytes exposed to laser-driven electron pulse and X-ray radiations. Additionally, we evaluated the effects on cell survival of in vitro tumor cells after exposure to laser-driven electron pulse compared to electron beams produced by a conventional radiofrequency accelerator used for intraoperative radiation therapy. Blood samples from two different donors were exposed to six radiation doses ranging from 0 to 2 Gy. Relative biological effectiveness (RBE) for micronucleus induction was calculated from the alpha coefficients for electrons compared to X rays (RBE = alpha laser/alpha X rays). Cell viability was monitored in the OVCAR-3 ovarian cancer cell line using trypan blue exclusion assay at day 3, 5 and 7 postirradiation (2, 4, 6, 8 and 10 Gy). The RBE values obtained by comparing the alpha values were 1.3 and 1.2 for the two donors. Mean telomere length was also found to be reduced in a significant dose-dependent manner after irradiation with both electrons and X rays in both donors studied. Our findings showed a radiobiological response as mirrored by the induction of micronuclei and shortening of telomere as well as by the reduction of cell survival in blood samples and cancer cells exposed in vitro to laser-generated electron bunches. Additional studies are needed to improve preclinical validation of the radiobiological characteristics and efficacy of laser-driven electron accelerators in the future.
Journal of Molecular and Cellular Cardiology | 2013
Saverio Sabina; Silvia Pulignani; Milena Rizzo; Monica Cresci; Cecilia Vecoli; Ilenia Foffa; Lamia Ait-Ali; Letizia Pitto; Maria Grazia Andreassi
Pediatric Cardiology | 2013
Monica Cresci; Ilenia Foffa; Lamia Ait-Ali; Silvia Pulignani; Alessandra Kemeny; Emilio Antonio Luca Gianicolo; Maria Grazia Andreassi